2025 Q4 -tulosraportti
Vain PDF
6 päivää sitten
Tarjoustasot
First North Denmark
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 250 | - | - | ||
| 750 | - | - | ||
| 780 | - | - | ||
| 270 | - | - | ||
| 1 000 | - | - |
Ylin
1,26VWAP
Alin
1,205VaihtoMäärä
0,1 44 537
VWAP
Ylin
1,26Alin
1,205VaihtoMäärä
0,1 44 537
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 44 537 | 44 537 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 44 537 | 44 537 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 30.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 t sittenAcquisitions drive market leadership and margin expansion https://analystgroup.se/analyser/stenocare-q4-25/
·1 päivä sittenThink carefully before you sell - in a while there will be stock price increases - but it's your choice.·9 t sittenMost of my savings are placed in larger, well-established companies. Then I have a smaller pot of money where I allow myself to take greater risks. But even in First North, there's no reason to actively seek out losses, which is what you do when you naively solely focus on all the positive while completely forgetting/refusing to be critical. If you invest that way, then you are a dreamer. And there are many dreamers on Shareville. They lose money, as they have done in bioporto, shape, Brain+ and, who knows, maybe also in Stenocare.
·1 päivä sittenHi, I initially hadn't intended to comment further as I believe the presented facts speak for themselves, so this will be my last post on this matter. In response to 'Onkel Charly' and '3D' and 'Blueoceanguy' as well as 'Jhonnykuskus', all four of whom show irritation in their posts where they have responded quite aggressively to my post on the 26th Feb. I have the following to say: It is, of course, up to each individual to analyze the companies they are interested in. One also doesn't need to share their views if they don't want to. But if one wants to share their views, they have every right to do so. There is absolutely nothing inappropriate in comparing companies within the same industry, and in pointing out the strengths and weaknesses available. Positive and negative facts are always important for an investor to take heed of, and one should remember that the reason these forums exist is so that fellow human beings can help each other make the right decisions. We all have the right to submit comments, questions, answers, and opinions. However, it should be done in a constructive, proper, and sympathetic manner. I believe Stenocare's quarterly report was very weak, while at the same time I see that their Swedish competitor ODI Pharma presents a strong result with profit and a quarterly revenue that is a full three times as large as Stenocare's. The significantly negative cash flow reported by Stenocare's management of minus 5.2 million Swedish kronor (!) is an obvious risk. Even if the upcoming quarter period theoretically could show that Stenocare is on the right track with their net revenue, this is only a small part of the solution required. Typically, it is not exclusively revenue and net profit that show how a company is performing. It is the cash flow that has the absolute greatest significance. Without a positive cash flow, the business cannot continue. Note that in Stenocare's case, the reported revenue for the quarter was 3.7 million Swedish kronor, at the exchange rate for the day, but the cash flow was, as mentioned, minus 5.2 million Swedish kronor (!). That the company is bleeding heavily is therefore a fact, and this is obviously not sustainable. It can only be a matter of time (in the near future) before management has to bite the bullet and make decisions to secure future finances. Stenocare's history of regularly raising capital will not make it easy when the cash is depleted, and a cold shoulder from most shareholders is therefore reasonable to predict. I agree with 'Onkel Charly' that these views are negative, but I find it hard to see the logic in his assertion that I should keep this to myself. ???? Only management or a company representative would support this crazy claim, I would think. I will leave 'Onkel Charly's' following comment with the question about chickens unanswered. But the question is quite strange, and one might wonder why 'Unkel Charly' brings this up, and what his relationship to the company is. As one can see, he has been a member of this forum for 9 years. He has three followers but does not follow anyone himself. Could it be that he knows very well what the problem looks like and that he sees the facts presented as an attack???? The same applies to '3D' who replied that the post made should be removed. (Furthermore, '3D' later gave a thumbs up to 'Onkel Charly's' comment about removing the post in a gesture of sympathy). Why did the post become sensitive for '3D' and 'Onkel Charly', one might ask? Everything presented in the post was taken directly from the companies' quarterly reports where the figures speak for themselves. With all the posts '3D' has made, one must ask if the person has any particular interest in maintaining a positive tone in everything written about Stenocare. In his latest post, he feels compelled to emphasize that The Analyst Group "also" is positive about Stenocare's actions. Note that Stenocare pays The Analyst Group for their analyses, and I think we can leave the rest unsaid. Everyone gets to make their own decisions. ;-) Regards
·1 päivä sittenI have no shares in either Steno or ODI, but if I had chosen, I would probably have taken Steno. However, I highly praise Cantourage Group, and I believe people should look this way instead of these two amateur stocks compared to it. I wonder if you have ODI shares, dear Andy? :D :D :D- ·2 päivää sittenAre the chickens now entering the market?
- ·2 päivää sittenAndy723 I thought it would be a a good idea if you kept your negative views to yourself.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
6 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenAcquisitions drive market leadership and margin expansion https://analystgroup.se/analyser/stenocare-q4-25/
- ·1 päivä sittenThink carefully before you sell - in a while there will be stock price increases - but it's your choice.·9 t sittenMost of my savings are placed in larger, well-established companies. Then I have a smaller pot of money where I allow myself to take greater risks. But even in First North, there's no reason to actively seek out losses, which is what you do when you naively solely focus on all the positive while completely forgetting/refusing to be critical. If you invest that way, then you are a dreamer. And there are many dreamers on Shareville. They lose money, as they have done in bioporto, shape, Brain+ and, who knows, maybe also in Stenocare.
- ·1 päivä sittenHi, I initially hadn't intended to comment further as I believe the presented facts speak for themselves, so this will be my last post on this matter. In response to 'Onkel Charly' and '3D' and 'Blueoceanguy' as well as 'Jhonnykuskus', all four of whom show irritation in their posts where they have responded quite aggressively to my post on the 26th Feb. I have the following to say: It is, of course, up to each individual to analyze the companies they are interested in. One also doesn't need to share their views if they don't want to. But if one wants to share their views, they have every right to do so. There is absolutely nothing inappropriate in comparing companies within the same industry, and in pointing out the strengths and weaknesses available. Positive and negative facts are always important for an investor to take heed of, and one should remember that the reason these forums exist is so that fellow human beings can help each other make the right decisions. We all have the right to submit comments, questions, answers, and opinions. However, it should be done in a constructive, proper, and sympathetic manner. I believe Stenocare's quarterly report was very weak, while at the same time I see that their Swedish competitor ODI Pharma presents a strong result with profit and a quarterly revenue that is a full three times as large as Stenocare's. The significantly negative cash flow reported by Stenocare's management of minus 5.2 million Swedish kronor (!) is an obvious risk. Even if the upcoming quarter period theoretically could show that Stenocare is on the right track with their net revenue, this is only a small part of the solution required. Typically, it is not exclusively revenue and net profit that show how a company is performing. It is the cash flow that has the absolute greatest significance. Without a positive cash flow, the business cannot continue. Note that in Stenocare's case, the reported revenue for the quarter was 3.7 million Swedish kronor, at the exchange rate for the day, but the cash flow was, as mentioned, minus 5.2 million Swedish kronor (!). That the company is bleeding heavily is therefore a fact, and this is obviously not sustainable. It can only be a matter of time (in the near future) before management has to bite the bullet and make decisions to secure future finances. Stenocare's history of regularly raising capital will not make it easy when the cash is depleted, and a cold shoulder from most shareholders is therefore reasonable to predict. I agree with 'Onkel Charly' that these views are negative, but I find it hard to see the logic in his assertion that I should keep this to myself. ???? Only management or a company representative would support this crazy claim, I would think. I will leave 'Onkel Charly's' following comment with the question about chickens unanswered. But the question is quite strange, and one might wonder why 'Unkel Charly' brings this up, and what his relationship to the company is. As one can see, he has been a member of this forum for 9 years. He has three followers but does not follow anyone himself. Could it be that he knows very well what the problem looks like and that he sees the facts presented as an attack???? The same applies to '3D' who replied that the post made should be removed. (Furthermore, '3D' later gave a thumbs up to 'Onkel Charly's' comment about removing the post in a gesture of sympathy). Why did the post become sensitive for '3D' and 'Onkel Charly', one might ask? Everything presented in the post was taken directly from the companies' quarterly reports where the figures speak for themselves. With all the posts '3D' has made, one must ask if the person has any particular interest in maintaining a positive tone in everything written about Stenocare. In his latest post, he feels compelled to emphasize that The Analyst Group "also" is positive about Stenocare's actions. Note that Stenocare pays The Analyst Group for their analyses, and I think we can leave the rest unsaid. Everyone gets to make their own decisions. ;-) Regards·1 päivä sittenI have no shares in either Steno or ODI, but if I had chosen, I would probably have taken Steno. However, I highly praise Cantourage Group, and I believe people should look this way instead of these two amateur stocks compared to it. I wonder if you have ODI shares, dear Andy? :D :D :D
- ·2 päivää sittenAre the chickens now entering the market?
- ·2 päivää sittenAndy723 I thought it would be a a good idea if you kept your negative views to yourself.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 250 | - | - | ||
| 750 | - | - | ||
| 780 | - | - | ||
| 270 | - | - | ||
| 1 000 | - | - |
Ylin
1,26VWAP
Alin
1,205VaihtoMäärä
0,1 44 537
VWAP
Ylin
1,26Alin
1,205VaihtoMäärä
0,1 44 537
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 44 537 | 44 537 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 44 537 | 44 537 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 30.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
6 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 30.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenAcquisitions drive market leadership and margin expansion https://analystgroup.se/analyser/stenocare-q4-25/
- ·1 päivä sittenThink carefully before you sell - in a while there will be stock price increases - but it's your choice.·9 t sittenMost of my savings are placed in larger, well-established companies. Then I have a smaller pot of money where I allow myself to take greater risks. But even in First North, there's no reason to actively seek out losses, which is what you do when you naively solely focus on all the positive while completely forgetting/refusing to be critical. If you invest that way, then you are a dreamer. And there are many dreamers on Shareville. They lose money, as they have done in bioporto, shape, Brain+ and, who knows, maybe also in Stenocare.
- ·1 päivä sittenHi, I initially hadn't intended to comment further as I believe the presented facts speak for themselves, so this will be my last post on this matter. In response to 'Onkel Charly' and '3D' and 'Blueoceanguy' as well as 'Jhonnykuskus', all four of whom show irritation in their posts where they have responded quite aggressively to my post on the 26th Feb. I have the following to say: It is, of course, up to each individual to analyze the companies they are interested in. One also doesn't need to share their views if they don't want to. But if one wants to share their views, they have every right to do so. There is absolutely nothing inappropriate in comparing companies within the same industry, and in pointing out the strengths and weaknesses available. Positive and negative facts are always important for an investor to take heed of, and one should remember that the reason these forums exist is so that fellow human beings can help each other make the right decisions. We all have the right to submit comments, questions, answers, and opinions. However, it should be done in a constructive, proper, and sympathetic manner. I believe Stenocare's quarterly report was very weak, while at the same time I see that their Swedish competitor ODI Pharma presents a strong result with profit and a quarterly revenue that is a full three times as large as Stenocare's. The significantly negative cash flow reported by Stenocare's management of minus 5.2 million Swedish kronor (!) is an obvious risk. Even if the upcoming quarter period theoretically could show that Stenocare is on the right track with their net revenue, this is only a small part of the solution required. Typically, it is not exclusively revenue and net profit that show how a company is performing. It is the cash flow that has the absolute greatest significance. Without a positive cash flow, the business cannot continue. Note that in Stenocare's case, the reported revenue for the quarter was 3.7 million Swedish kronor, at the exchange rate for the day, but the cash flow was, as mentioned, minus 5.2 million Swedish kronor (!). That the company is bleeding heavily is therefore a fact, and this is obviously not sustainable. It can only be a matter of time (in the near future) before management has to bite the bullet and make decisions to secure future finances. Stenocare's history of regularly raising capital will not make it easy when the cash is depleted, and a cold shoulder from most shareholders is therefore reasonable to predict. I agree with 'Onkel Charly' that these views are negative, but I find it hard to see the logic in his assertion that I should keep this to myself. ???? Only management or a company representative would support this crazy claim, I would think. I will leave 'Onkel Charly's' following comment with the question about chickens unanswered. But the question is quite strange, and one might wonder why 'Unkel Charly' brings this up, and what his relationship to the company is. As one can see, he has been a member of this forum for 9 years. He has three followers but does not follow anyone himself. Could it be that he knows very well what the problem looks like and that he sees the facts presented as an attack???? The same applies to '3D' who replied that the post made should be removed. (Furthermore, '3D' later gave a thumbs up to 'Onkel Charly's' comment about removing the post in a gesture of sympathy). Why did the post become sensitive for '3D' and 'Onkel Charly', one might ask? Everything presented in the post was taken directly from the companies' quarterly reports where the figures speak for themselves. With all the posts '3D' has made, one must ask if the person has any particular interest in maintaining a positive tone in everything written about Stenocare. In his latest post, he feels compelled to emphasize that The Analyst Group "also" is positive about Stenocare's actions. Note that Stenocare pays The Analyst Group for their analyses, and I think we can leave the rest unsaid. Everyone gets to make their own decisions. ;-) Regards·1 päivä sittenI have no shares in either Steno or ODI, but if I had chosen, I would probably have taken Steno. However, I highly praise Cantourage Group, and I believe people should look this way instead of these two amateur stocks compared to it. I wonder if you have ODI shares, dear Andy? :D :D :D
- ·2 päivää sittenAre the chickens now entering the market?
- ·2 päivää sittenAndy723 I thought it would be a a good idea if you kept your negative views to yourself.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 250 | - | - | ||
| 750 | - | - | ||
| 780 | - | - | ||
| 270 | - | - | ||
| 1 000 | - | - |
Ylin
1,26VWAP
Alin
1,205VaihtoMäärä
0,1 44 537
VWAP
Ylin
1,26Alin
1,205VaihtoMäärä
0,1 44 537
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 44 537 | 44 537 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 44 537 | 44 537 | 0 | 0 |